Life sciences · Journal article
Research in Veterinary Science · September 20, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Bovine mastitis is the costliest infectious disease in dairy farming worldwide and a major driver of antimicrobial use. The increasing prevalence of antimicrobial resistance (AMR) in mastitis pathogens has elevated this condition to a One Health perspective. A retrospective analytical observational study was conducted from 540 quarter-milk samples collected from 419 cows across 123 farms collected between June 2023 and January 2026, from dairy cows with clinical or subclinical mastitis. Bacterial identification and antimicrobial susceptibility testing were performed using the Mastatest® automated system. Risk factors were assessed using binomial generalized linear mixed models (GLMMs), including dairy farm as a random intercept. Environmental pathogens such as Escherichia coli (25.7%) and Streptococcus uberis (23.7%) were the predominant pathogens identified. Conventional milking, udder alterations, and impaired general condition were associated with higher odds of E. coli isolation, whereas recurrent mastitis was associated with lower odds (all p < 0.05). Recurrent mastitis was the only factor significantly associated with S. uberis isolation (p = 0.037). Among Gram-positive monobacterial isolates, co-resistance to ≥2 antibiotic classes was detected in 10.5% overall; Streptococcus spp. showed the highest resistance rates, particularly to cloxacillin (42.9%), benzylpenicillin (25.0%) and macrolides (21.4%). No significant predictors of co-resistance were identified. Antibiotic resistance patterns observed in mastitis pathogens support the implementation of culture-guided antimicrobial therapy and provide baseline data for regional AMR surveillance within a One Health approach.